Article · Wikipedia archive · Last revised Jun 17, 2026

DODC

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020, though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

Last revised
Jun 17, 2026
Read time
≈ 1 min
Length
116 w
Citations
1
Source
Wikipedia ↗
DODC
Identifiers
  • 1-(2,5-dimethoxy-3,4-dichlorophenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC11H15Cl2NO2
Molar mass264.15 g·mol−1
3D model (JSmol)
  • Clc1c(OC)cc(CC(C)N)c(OC)c1Cl
  • InChI=1S/C11H15Cl2NO2/c1-6(14)4-7-5-8(15-2)9(12)10(13)11(7)16-3/h5-6H,4,14H2,1-3H3
  • Key:IGOFLAWWDQNRCV-UHFFFAOYSA-N

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020,1 though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

See also

See also

References

References

  1. WO 2022/006186, Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", published January 2022, assigned to Gilgamesh Pharmaceuticals.